BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1759273)

  • 1. [Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].
    Mischke R; Nolte I
    Tierarztl Prax; 1991 Oct; 19(5):561-6. PubMed ID: 1759273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
    Mischke R; Grebe S
    Res Vet Sci; 2000 Dec; 69(3):241-7. PubMed ID: 11124095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
    Moreno P; Ginel PJ
    Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M; Fey MF; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
    Mineo HK; Garabed RB
    Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
    Mischke R; Junker J; Deegen E
    Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is the activated partial thromboplastin time suitable for monitoring of thrombosis therapy with high-dose standard heparin?].
    Hürzeler C; von Felten A
    Schweiz Med Wochenschr; 1994 Apr; 124(17):712-9. PubMed ID: 8202668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-stage prothrombin time, activated partial thromboplastin time, thrombin time, fibrin degradation product concentration, and antithrombin activity in healthy adult alpacas.
    House AM; Barton MH; Williamson LH
    Vet Clin Pathol; 2011 Jun; 40(2):195-7. PubMed ID: 21554362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of heparin therapy with activated recalcification time].
    Lutze G; Schlote A; Urbahn H
    Z Gesamte Inn Med; 1981 Feb; 36(4):102-6. PubMed ID: 7222858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimentally induced bluetongue virus infection in white-tailed deer: coagulation, clinical pathologic, and gross pathologic changes.
    Howerth EW; Greene CE; Prestwood AK
    Am J Vet Res; 1988 Nov; 49(11):1906-13. PubMed ID: 2854709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hexadimethrine bromide as a heparin-neutralizing agent in canine plasma.
    Green RA; LaFollette KA; Greig B
    Am J Vet Res; 1987 Mar; 48(3):496-8. PubMed ID: 3565907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
    Gerhards H; Eberhardt C
    Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.